m6A modification of mutant huntingtin RNA promotes the biogenesis of pathogenic huntingtin transcripts

Authors:

Abstract
In Huntington’s disease (HD), aberrant processing of huntingtin ( HTT ) mRNA produces HTT1a transcripts that encode the pathogenic HTT exon 1 protein. The mechanisms behind HTT1a production are not fully understood. Considering the role of m 6 A in RNA processing and splicing, we investigated its involvement in HTT1a generation. Here, we show that m 6 A methylation is increased before the cryptic poly(A) sites (IpA1 and IpA2) within the huntingtin RNA in the striatum of Hdh+/Q111 mice and human HD samples. We further assessed m 6 A’s role in mutant Htt mRNA processing by pharmacological inhibition and knockdown of METTL3, as well as targeted demethylation of Htt intron 1 using a dCas13-ALKBH5 system in HD mouse cells. Our data reveal that Htt1a transcript levels are regulated by both METTL3 and the methylation status of Htt intron 1. They also show that m 6 A methylation in intron 1 depends on expanded CAG repeats. Our findings highlight a potential role for m 6 A in aberrant splicing of Htt mRNA.
Funding Information
  • Huntington's Disease Foundation
  • Ministerio de Ciencia, Innovación y Universidades (PID2020-116474RB-100)
  • Ministerio de Ciencia, Innovación y Universidades (PID2020-113953RB-I00)
  • Ministerio de Ciencia, Innovación y Universidades (RTI2018-094374-B100)
  • Ministerio de Ciencia, Innovación y Universidades (RE2021-097199)
  • National Institutes of Health (R01 NS126420)
  • Generalitat de Catalunya (2018FI_B00487)